$244.52
+0.42
(+0.17%)▲
Live
Cigna Corp is a global health service company that provides medical, dental, and disability insurance plans.
Revenue is up for the last 3 quarters, 45.19B → 46.51B (in $), with an average increase of 1.4% per quarter
Netprofit is down for the last 3 quarters, 2.75B → 39.0M (in $), with an average decrease of 77.1% per quarter
In the last 1 year, Humana Inc. has given 7.7% return, outperforming this stock by 18.1%
1.27%
Downside
Day's Volatility :1.27%
Upside
0.0%
2.56%
Downside
52 Weeks Volatility :29.64%
Upside
27.8%
Period | Cigna Corp. | Sector (Health Care) | S&P500 |
---|---|---|---|
3 Months | -16.43% | 0.3% | 5.9% |
6 Months | -25.78% | -8.3% | 3.1% |
1 Year | -9.02% | -4.8% | 1.1% |
3 Years | 23.22% | 23.8% | 38.1% |
Market Capitalization | 72.2B |
Book Value | $150.19 |
Dividend Share | 4.59 |
Dividend Yield | 1.99% |
Earnings Per Share (EPS) | 21.82 |
PE Ratio | 11.19 |
PEG Ratio | 1.22 |
Wall Street Target Price | 327.0 |
Profit Margin | 3.69% |
Operating Margin TTM | 4.39% |
Return On Assets TTM | 3.34% |
Return On Equity TTM | 15.07% |
Revenue TTM | 182.8B |
Revenue Per Share TTM | 601.61 |
Quarterly Revenue Growth YOY | 6.4% |
Gross Profit TTM | 23.0B |
EBITDA | 9.9B |
Diluted Eps TTM | 21.82 |
Quarterly Earnings Growth YOY | 0.14 |
EPS Estimate Current Year | 24.69 |
EPS Estimate Next Year | 28.22 |
EPS Estimate Current Quarter | 5.22 |
EPS Estimate Next Quarter | 6.26 |
What analysts predicted
Upside of 33.73%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 41.6B | ↑ 4.91% |
Net Income | 2.2B | ↑ 19.82% |
Net Profit Margin | 5.38% | ↑ 0.67% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 48.6B | ↑ 16.71% |
Net Income | 2.6B | ↑ 17.88% |
Net Profit Margin | 5.43% | ↑ 0.05% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 153.7B | ↑ 216.55% |
Net Income | 5.1B | ↑ 93.55% |
Net Profit Margin | 3.32% | ↓ 2.11% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 160.6B | ↑ 4.45% |
Net Income | 8.5B | ↑ 65.71% |
Net Profit Margin | 5.27% | ↑ 1.95% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 174.3B | ↑ 8.53% |
Net Income | 5.4B | ↓ 36.57% |
Net Profit Margin | 3.08% | ↓ 2.19% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 180.6B | ↑ 3.66% |
Net Income | 6.7B | ↑ 24.29% |
Net Profit Margin | 3.69% | ↑ 0.61% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Revenue | 45.8B | ↑ 3.24% |
Net Income | 1.1B | ↓ 31.15% |
Net Profit Margin | 2.44% | ↓ 1.22% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 43.7B | ↓ 4.55% |
Net Income | 1.2B | ↑ 6.0% |
Net Profit Margin | 2.71% | ↑ 0.27% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 45.4B | ↑ 3.89% |
Net Income | 1.6B | ↑ 31.78% |
Net Profit Margin | 3.44% | ↑ 0.73% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 45.2B | ↓ 0.41% |
Net Income | 2.8B | ↑ 76.84% |
Net Profit Margin | 6.1% | ↑ 2.66% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 45.7B | ↑ 1.2% |
Net Income | 1.2B | ↓ 57.6% |
Net Profit Margin | 2.56% | ↓ 3.54% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 46.5B | ↑ 1.69% |
Net Income | 39.0M | ↓ 96.66% |
Net Profit Margin | 0.08% | ↓ 2.48% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 61.8B | ↑ 4.03% |
Total Liabilities | 48.0B | ↑ 5.23% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 153.2B | ↑ 148.13% |
Total Liabilities | 112.2B | ↑ 133.64% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 155.8B | ↑ 1.66% |
Total Liabilities | 110.4B | ↓ 1.57% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 155.5B | ↓ 0.21% |
Total Liabilities | 105.1B | ↓ 4.81% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 154.9B | ↓ 0.36% |
Total Liabilities | 107.8B | ↑ 2.51% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Total Assets | 154.9B | ↑ 0.41% |
Total Liabilities | 107.8B | ↑ 0.88% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 152.6B | ↓ 1.47% |
Total Liabilities | 106.4B | ↓ 1.22% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 152.6B | ↑ 0.01% |
Total Liabilities | 106.7B | ↑ 0.2% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 144.2B | ↓ 5.52% |
Total Liabilities | 99.1B | ↓ 7.11% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 148.0B | - |
Total Liabilities | 103.4B | - |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 4.1B | ↑ 1.49% |
Investing Cash Flow | -1.7B | ↓ 33.84% |
Financing Cash Flow | -2.7B | ↑ 1078.22% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 3.8B | ↓ 7.73% |
Investing Cash Flow | -26.4B | ↑ 1448.91% |
Financing Cash Flow | 23.5B | ↓ 987.02% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 9.5B | ↑ 151.59% |
Investing Cash Flow | -734.0M | ↓ 97.22% |
Financing Cash Flow | -7.2B | ↓ 130.56% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 10.4B | ↑ 9.12% |
Investing Cash Flow | 3.0B | ↓ 505.45% |
Financing Cash Flow | -8.5B | ↑ 18.73% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 7.2B | ↓ 30.52% |
Investing Cash Flow | -3.6B | ↓ 221.34% |
Financing Cash Flow | -8.2B | ↓ 3.76% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.3B | ↑ 101.75% |
Investing Cash Flow | 123.0M | ↓ 117.32% |
Financing Cash Flow | -2.4B | ↑ 37.21% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.0B | ↓ 52.51% |
Investing Cash Flow | -324.0M | ↓ 363.41% |
Financing Cash Flow | -2.2B | ↓ 8.44% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.2B | ↓ 38.72% |
Investing Cash Flow | -408.0M | ↑ 25.93% |
Financing Cash Flow | -916.0M | ↓ 57.81% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 3.3B | ↑ 163.91% |
Investing Cash Flow | 4.4B | ↓ 1189.71% |
Financing Cash Flow | -5.5B | ↑ 502.29% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 5.0B | ↑ 139.54% |
Investing Cash Flow | -3.0B | - |
Financing Cash Flow | -37.0M | ↓ 98.6% |
Sell
Neutral
Buy
Cigna Corp. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Cigna Corp. | -4.24% | -25.78% | -9.02% | 23.22% | 40.84% |
![]() UnitedHealth Group Incorporated | -2.86% | -12.09% | -3.07% | 57.4% | 96.59% |
![]() CVS Health Corporation | -8.46% | -33.61% | -30.09% | 3.05% | 2.5% |
![]() Humana Inc. | -7.2% | -9.69% | 9.33% | 23.69% | 67.56% |
![]() Elevance Health, Inc | -5.59% | -16.33% | -5.75% | -5.75% | -5.75% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Cigna Corp. | 11.19 | 11.19 | 1.22 | 24.69 | 0.15 | 0.03 | 0.02 | 150.19 |
![]() UnitedHealth Group Incorporated | 22.03 | 22.03 | 1.66 | 23.29 | 0.25 | 0.07 | 0.01 | 87.25 |
![]() CVS Health Corporation | 22.47 | 22.47 | 1.36 | 8.61 | 0.05 | 0.04 | 0.04 | 55.81 |
![]() Humana Inc. | 20.12 | 20.12 | 1.28 | 28.36 | 0.19 | 0.06 | 0.01 | 132.67 |
![]() Elevance Health, Inc | 17.3 | 17.3 | 1.38 | 32.85 | 0.17 | 0.05 | 0.01 | 157.54 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Cigna Corp. | Buy | $72.2B | 40.84% | 11.19 | 3.69% |
![]() UnitedHealth Group Incorporated | Buy | $448.3B | 96.59% | 22.03 | 6.16% |
![]() CVS Health Corporation | Buy | $86.7B | 2.5% | 22.47 | 1.19% |
![]() Humana Inc. | Buy | $62.0B | 67.56% | 20.12 | 3.26% |
![]() Elevance Health, Inc | Buy | $105.7B | -5.75% | 17.3 | 3.87% |
BlackRock Inc
Vanguard Group Inc
FMR Inc
State Street Corporation
T. Rowe Price Associates, Inc.
Dodge & Cox
In the quarter ending March,2023. Cigna Corp. has declared dividend of $1.23
Read MoreCigna Corporation is a global health service company dedicated to improving the health, well-being and peace of mind of those we serve. Cigna delivers choice, predictability, affordability and access to quality care through integrated capabilities and connected, personalized solutions that advance whole person health. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Cigna Life Insurance Company of New York, Connecticut General Life Insurance Company, Evernorth companies or their affiliates, Express Scripts companies or their affiliates, and Life Insurance Company of North America. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products including group life, accident and disability insurance. Cigna maintains sales capability in over 30 countries and jurisdictions, and has more than 175 million customer relationships throughout the world.
Organization | Cigna Corp. |
Employees | 71300 |
CEO | Mr. David Michael Cordani |
Industry | Health Services |
Molina Healthcare, Inc.
$272.59
-0.16%
Mettler-Toledo International Inc.
$1,343.19
-0.37%
Biogen Inc.
$296.75
-0.64%
Penumbra Inc
$308.62
+0.69%
AmerisourceBergen Corp.
$166.89
-0.9%
Fresenius Medical Care AG & Co. KGAA
$21.63
+0.23%
Horizon Therapeutics Public Ltd Co
$99.65
+0.04%
Edwards Lifesciences Corp.
$81.77
-0.29%
BioMarin Pharmaceutical Inc.
$88.27
-0.24%